Infants and Toddlers at Highest Risk of Severe Outcomes from Multiple Viruses
With the COVID, flu and RSV tripledemic, new research spotlights the effects of COVID-19 variants and multiple viruses on young patients.
With the COVID, flu and RSV tripledemic, new research spotlights the effects of COVID-19 variants and multiple viruses on young patients.
The US FDA authorized use of the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test -- the first COVID-Flu-RSV test without the need for a prescription.
The FDA has granted Fast Track designation to Moderna's investigational single-dose mRNA-1345 vaccine against the respiratory syncytial virus (RSV) for people over 60 years of age.
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of...
Read MoreJohnson & Johnson is scrapping its investigational therapy for respiratory syncytial virus (RSV) and human metapneumovirus to the tune of a $900 million tax write-off.
Read MoreNew research suggests that respiratory syncytial virus (RSV) burden for infants under age 2 was 1.5-fold greater than previously believed.
Read MoreA team of investigators at Novavax Inc are at the cusp of the revolutionary development of a maternal vaccine for respiratory syncytial virus (RSV). The Maryland-based clinical-stage vaccine company intends to share data in the...
Read MoreA Phase 1 study will examine the safety of an experimental intranasal vaccine and its ability to induce an immune response to respiratory syncytial virus (RSV).
Read MoreRSV F is a respiratory syncytial virus F protein recombinant nanoparticle vaccine for infants via maternal immunization.
Read MoreRespiratory syncytial virus (RSV) can increase risk of cardiovascular complications for individuals with and without preexisting cardiovascular disease.
Read MorePregnant women infected with respiratory syncytial virus (RSV) can transmit the bug from their respiratory tract to the lungs of their unborn baby – resulting in altered immunity development after birth.
Read MoreThe Rocky Mountain Hospital for Children in Denver is currently “packed with children” suffering from respiratory syncytial virus (RSV).
Read MoreA phase 2a challenge study for GS-5806, an investigational oral RSV fusion inhibitor, found that the drug safely reduced the viral load and clinical illness of healthy adult volunteers who were intranasally infected with respiratory syncytial virus.
Read MoreNew devices are continuing the life-saving impact of bubble CPAP technology, which, since 1973, has saved thousands of newborns with severe respiratory illnesses.
Read MoreThrough trials with mice, researchers believe red ginseng extract improves the survival of human lung epithelial cells infected with the influenza A virus.
Read More